National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 94751 [2024-28000]
Download as PDF
<![CDATA[
94751
Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Proposed Collection Title: Generic
Clearance for the Collection of
Qualitative Feedback on Agency Service
Delivery (NIAID), 0925–0668,
Expiration Date 07/31/2025,
EXTENSION, National Institute of
Allergy and Infectious Diseases (NIAID).
Need and Use of Information
Collection: There are no changes being
requested for this submission. The
proposed information collection activity
provides a means to garner qualitative
customer and stakeholder feedback in
an efficient, timely manner, in
accordance with the Administration’s
commitment to improving service
delivery. By qualitative feedback we
mean information that provides useful
insights on perceptions and opinions
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide information
about the NIAID’s customer or
stakeholder perceptions, experiences
and expectations, provide an early
warning of issues with service, or focus
attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
NIAID and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours over
3 years are 7200 (2400 per year).
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of collection
Hours per
response
Total
hours
Customer satisfaction surveys .........................................................................
In-Depth Interviews (IDIs) or Small Discussion Groups ..................................
Individual Brief Interviews ................................................................................
Focus Groups ..................................................................................................
Pilot testing surveys .........................................................................................
Conferences and Training Pre- and Post-surveys ..........................................
Website or Software Usability Tests ................................................................
4000
20
40
30
20
500
20
1
1
1
1
1
1
1
30/60
90/60
15/60
2
30/60
30/60
2
2000
30
10
60
10
250
40
Total ..........................................................................................................
........................
4630
........................
2400
Dated: November 22, 2024.
Brandie K. Taylor Bumgardner,
Project Clearance Liaison, National Institutes
of Allergy and Infectious Diseases, National
Institutes of Health.
[FR Doc. 2024–27902 Filed 11–27–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
khammond on DSK9W7S144PROD with NOTICES
Annual
frequency per
response
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Study Section
Hoffert_2/25–27/2025.
Date: February 25–27, 2025.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
NIDDK, Democracy II, Suite 7000A, 6707
Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jason D. Hoffert, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard,
Bethesda, MD 20817, 301–496–9010,
hoffertj@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS).
Dated: November 22, 2024.
Miguelina Pere,z
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–28000 Filed 11–27–24; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
VerDate Sep<11>2014
21:22 Nov 27, 2024
Jkt 265001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
BRAIN Initiative K99/R00 Application
Review.
Date: December 13, 2024.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 89, Number 230 (Friday, November 29, 2024)]
[Notices]
[Page 94751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-28000]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Initial Review Group; Kidney, Urologic and
Hematologic Diseases D Study Section Hoffert_2/25-27/2025.
Date: February 25-27, 2025.
Time: 5 p.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, NIDDK, Democracy II,
Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jason D. Hoffert, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7343, 6707 Democracy Boulevard, Bethesda, MD 20817, 301-496-
9010, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS).
Dated: November 22, 2024.
Miguelina Pere,z
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-28000 Filed 11-27-24; 8:45 am]
BILLING CODE 4140-01-P
